Quarterly Results- overall
Annual Results- Scale
Annual Results- Liquidity
Annual Results- Profitability/Return
Annual Results- Valuation
External Ecosystem
Sector
Major Subsidiaries/Associates
Key Clients
Products
Products
Product details
Operations
Capacity/ Production
Key Facilities
Key Certifications
Raw materials
Recent News
|
Dr. Lal PathLabs Limited Estimates – NSE:LALPATHLAB
Read More
|
|
Dr. Lal PathLabs (NSEI:LALPATHLAB) Stock Forecast & Analyst Predictions
Read More
|
|
Dr Lal PathLabs acquires remaining 30% stake in Centrapath Labs
Read More
|
|
Dr Lal PathLabs faces ITAT appeal over ?32.66 crore ESOP expense disallowance
Read More
|
|
Dr Lal PathLabs invests Rs 30.3 crore in PUPL
Read More
|
|
Dr. Lal PathLabs Subsidiary PUPL Completes Purchase Of Final 30% Stake In Centrapath Labs
Read More
|
|
Axis Direct bullish on Dr Lal PathLabs, Vijaya Diagnostic and Nephrocare, assigns 'Buy' ratings with up to...
Read More
|
|
Dr. Lal Pathlabs Share Price rises 2.2% on valuation focus
Read More
|
|
I-T dept moves appellate tribunal against Rs 32.66-cr tax relief to Dr Lal PathLabs
Read More
|
|
Dr Lal PathLabs receives intimation of IT dept appeal before ITAT for AY 2022-23
Read More
|
|
Five Stocks To Buy Today: Lal PathLabs, Indus Towers, Cyient And More | October 5
Read More
|
|
Stock Radar: Dr Lal PathLabs stock hits fresh record high in September; will the rally continue in October
Read More
|
|
Big Healthcare Expansion! Dr Lal PathLabs Seals SN Genelab Acquisition
Read More
|
|
Dr Lal PathLabs completes SN Genelab stake acquisition
Read More
|